Adrian Johnson

“`html TLDR: Flourish Ventures announced new hires and promotions, strengthening its global investment team. The firm expanded its presence in India, LatAm, US, and Africa, focusing on mission-driven fintech founders. Flourish Ventures,

TLDR: Avail, a Web3 data availability and consensus layer, has closed a $27 million seed funding round led by Founders Fund and Dragonfly. The funds will be used to accelerate the development

TLDR: AVAC Group officially rebrands as Verdex Capital, focusing on Canadian agricultural innovation. Verdex Capital invests directly through its AgTech venture studio, Carrot Ventures, launched in partnership with Farm Credit Canada. The

TLDR: Private equity and venture capital firms are utilizing external data sources, known as “alternative data,” to identify investment opportunities and add value post-investment. AI is becoming a disruptive force, but its

TLDR: Key Points: Vietnamese EdTech startup NativeX secures $4 million in funding within 8 months of its inception. The funding will be used to expedite product development and launch new program offerings.

TLDR: FAMS, a parenting app, raised $400K in pre-seed funding led by SMOK Ventures. The app provides personalized child development programs and strategies for parents. FAMS, a parenting app designed to support

TLDR: Blume Ventures has made its largest maiden investment of $10 million in Interview Kickstart, an edtech firm based in the US. Interview Kickstart is a platform for technology professionals looking to

TLDR: The Conference Board of Canada released a report suggesting generative AI could boost Canada’s GDP by nearly two percent. Golden Ventures closes nearly $140 million CAD for fifth seed-stage VC fund.

TLDR: AVAC Group changed its name to Verdex Capital to focus on the Canadian agricultural sector. Verdex Capital aims to invest in high-impact ventures with triple-bottom-line outcomes. Verdex Capital, previously known as

TLDR: Biotech’s top money raisers for 2023 were announced across various platforms. The top fundraisers included companies in the biotech, cell & gene therapy, clinical data, and venture capital sectors. In 2023,